CDD Vault User Testimonials

“CDD Vault gives us the ability to see the data as it’s put into the database with very little training. So it’s easy and intuitive to do.”

Jim Wikel
Apex Therapeutics
CDD Scientific Advisory Board

“CDD easily allows us to securely collaborate, while keeping some data private, all in one system.”

Ellen Berg, PhD

“CDD Vault is a lifesaver. We really needed a way to capture the data we were creating and be able [to] share and analyze it — before we were capturing data on spreadsheets.”

Malcolm Kendall
President & CEO, Indel Therapeutics, Inc.

“It’s a great tool for mining and sharing data with collaborators. I’ve used a couple of other programs, but they don’t put everything together so intuitively.”

Mary Lynn Baniecki, PhD
Harvard Medical School

“The CDD Database is an extremely elegant platform. I highly recommend it for anyone generating drug discovery data.”

Bryan Roth, MD, PhD
University of North Carolina

“We had Excel sheets all over the place and data from different projects that were just separated in different folders and after a while, it got to the point that it was just hard to manage. We chose CDD, and we’re really happy with the service and the cost and the way the database is evolving.”

Ruo Steensma, PhD
Director of Chemistry, Orphagen Pharmaceuticals

“CDD Vault presents data and associated tools that capture the relationship between chemical structure and biological activity. Structure-Activity Relationship (SAR) data substantially improve the distributed drug discovery process.”

Christopher Lipinski, PhD
Pfizer, Retired
CDD Scientific Advisory Board

“We looked at many options for a chemistry database. CDD is an economical and effective solution: the flexible web-based interface without need for internal IT support fits our small company requirements very well. And CDD is fun to work with.”

Scott Thacher, PhD
CEO, Orphagen Pharmaceuticals

“Five years ago our lab tested 20 compounds a year with no way to handle 200. Today, with CDD’s software, we can fully process 3,000 new compounds per year and advance the best compounds to late-stage development.”

Dr. James McKerrow
CDD Scientific Advisory Board

“Your application is remarkably impressive – there is no other word to describe it (and I’ve seen lots of other applications). Just the performance is mind-boggling!”

Yannick Pouliot, PhD, MBA
Bioresearch Informationist, major research university in the SF Bay Area

“If it’s not in CDD, it didn’t happen.”

Rob Gillespie
Research Scientist/Engineer, University of Washington

“It is a Must Have! CDD is a 21st century tool and has the potential to not only change drug discovery of orphan diseases but if inoculated with enough data all of drug discovery will benefit.”

Garrett Moraski
Montana State University

Translated with Google Translate